Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer

Clin J Oncol Nurs. 2019 Oct 1;23(5):494-501. doi: 10.1188/19.CJON.494-501.

Abstract

Background: Taxane-induced peripheral neuropathy (TIPN) is caused by the neurotoxicity of paclitaxel and docetaxel, but the differences between paclitaxel- and docetaxel-induced peripheral neuropathy are understudied.

Objectives: The purpose of this study is to compare TIPN between docetaxel and paclitaxel in patients with breast cancer and to examine the consistency of measuring TIPN between researchers and patients.

Methods: Secondary data were analyzed from a cross-sectional study that included 64 patients with breast cancer from two teaching hospitals in Taiwan. Objective and subjective TIPN were measured.

Findings: Results indicated significant differences in objective TIPN, sensory sum score, and motor sum score between groups. No significant difference was detected in subjective TIPN between groups.

Keywords: breast cancer; docetaxel; paclitaxel; taxane-induced peripheral neuropathy.

MeSH terms

  • Aged
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / physiopathology
  • Cross-Sectional Studies
  • Docetaxel / adverse effects*
  • Female
  • Humans
  • Middle Aged
  • Paclitaxel / adverse effects*
  • Peripheral Nervous System Diseases / chemically induced*
  • Quality of Life

Substances

  • Antineoplastic Agents, Phytogenic
  • Docetaxel
  • Paclitaxel